ORTHOREBIRTH specializes in developing innovative solutions for regenerative medicine, focusing on synthetic bone void fillers and cell culture technologies. Their flagship product, ReBOSSIS, is a cottony type synthetic bone void filling material that leverages proprietary Microfiber Producing Technology. This product is designed to be bioabsorbable and serves as an effective scaffolding material, making it highly suitable for various medical applications. The company collaborates with universities, institutions, and businesses to advance regenerative medicine, and has received R&D subsidies from Okinawa Prefecture to further their research. ORTHOREBIRTH generates revenue through the commercialization of its products, targeting research institutions and medical facilities that require advanced materials for regenerative treatments.

Keywords: synthetic bone void fillers, regenerative medicine, ReBOSSIS, Microfiber Technology, bioabsorbable, scaffolding material, cell culture, R&D, medical applications, commercialization.